Bartlett & Co’s Idexx Laboratories IDXX Stock Holding History

Bartlett & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$111K	Hold	200	–	–	﹤0.01%	556
2023 Q3	$87K	Hold	200	–	–	﹤0.01%	566
2023 Q2	$100K	Hold	200	–	–	﹤0.01%	543
2023 Q1	$100K	Hold	200	–	–	﹤0.01%	466
2022 Q4	$82K	Sell	200 -7	-3%	-$2.72K	﹤0.01%	502
2022 Q3	$67K	Sell	207 -19	-8%	-$6.98K	﹤0.01%	519
2022 Q2	$79K	Buy	226 +26	+13%	+$10.6K	﹤0.01%	503
2022 Q1	$109K	Buy	+200	New	+$105K	﹤0.01%	476
2021 Q4	–	Sell	-200	Closed	-$124K	–	624
2021 Q3	$124K	Hold	200	–	–	﹤0.01%	387
2021 Q2	$126K	Hold	200	–	–	﹤0.01%	384
2021 Q1	$98K	Sell	200 -200	-50%	-$100K	﹤0.01%	418
2020 Q4	$200K	Hold	400	–	–	﹤0.01%	329
2020 Q3	$157K	Hold	400	–	–	﹤0.01%	331
2020 Q2	$132K	Sell	400 -42	-10%	-$12.2K	﹤0.01%	356
2020 Q1	$107K	Buy	+442	New	+$115K	﹤0.01%	361
2019 Q3	$120K	Buy	+442	New	+$123K	﹤0.01%	377
2013 Q4	–	Sell	-24	Closed	-$1K	–	731
2013 Q3	$1K	Buy	+24	New	+$1.15K	﹤0.01%	783

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bartlett & Co's IDXX Position: Q4 2023 in Review

Bartlett & Co held its Idexx Laboratories (IDXX) position steady in Q4 2023 at 200 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Bartlett & Co first reported a position in IDXX in Q3 2013 and has held it in 17 quarters since. The position peaked at $200K in Q4 2020. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Bartlett & Co held 200 shares of Idexx Laboratories worth $111K as of Q4 2023.
Bartlett & Co left its Idexx Laboratories share count unchanged in Q4 2023.
Idexx Laboratories made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #556 holding.
Bartlett & Co first reported a position in Idexx Laboratories in Q3 2013 and has held it in 17 quarters since.
Bartlett & Co's Idexx Laboratories position peaked at $200K in Q4 2020.
1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.